The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Sharon Osbourne has opened up about the devastating toll that Parkinson's disease has taken on her husband, Ozzy Osbourne.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Nearly 90,000 people a year are diagnosed with Parkinson's disease, and it's the second most common neurodegenerative disease after Alzheimer's. "It impacts many different systems in the body ...

Human 'domainome' reveals root cause of heritable disease Unstable proteins drive many different types of genetic disorders, according to new research Date: January 8, 2025 Source: Center for ...

2024 — Dementia with Lewy bodies is a type of dementia that is similar to both Alzheimer's disease and Parkinson's disease but studies on long-term treatments are lacking. A new study highlights ...

A new discovery in blood immune cells has put researchers one step closer to identifying a blood biomarker that would allow doctors to personalize treatments for Parkinson's disease. In a multi ...